0Q

Medios AGLSE Medios Stock Report

Last reporting period 30 Jun, 2024

Updated 01 Nov, 2024

Last price

Market cap $B

0.463

Micro

Exchange

XLON - London Stock Exchange

0QB4.L Stock Analysis

0Q

Avoid

Based on Eyestock quantitative analysis, 0QB4.L`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

48/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

17.4 %

Undervalued

Market cap $B

0.463

Dividend yield

Shares outstanding

23.806 B

Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. The company is headquartered in Berlin, Berlin and currently employs 514 full-time employees. The company wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The firm also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.

View Section: Eyestock Rating